Structural modifications of bacterial lipopolysaccharide that facilitate gram-negative bacteria evasion of host innate immunity

Frontiers in Immunology

Volumn 4, Issue MAY, 2013, Pages

  Matsuura, Motohiro ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

Immune evasion; Innate immunity; Less acylated lipid A; Modification of lipopolysaccharide

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; FLAGELLIN; LIPID A; PROTEIN MD 2; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 5; VIRULENCE FACTOR;

ACETYLATION; FLEA; FRANCISELLA TULARENSIS; GRAM NEGATIVE BACTERIUM; HELICOBACTER PYLORI; HUMAN; IMMUNE EVASION; INNATE IMMUNITY; NONHUMAN; PATTERN RECOGNITION; PLAGUE; PORPHYROMONAS GINGIVALIS; REVIEW; TULAREMIA; YERSINIA PESTIS;

EID: 84883809384     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2013.00109     Document Type: Review

References (82)

1. Airhart, C. L., Rohde, H. N., Bohach, G. A., Hovde, C. J., Deobald, C. F., Lee, S. S., et al. (2008). Induction of innate immunity by lipid A mimetics increases survival from pneumonic plague. Microbiology 154, 2131-2138.
2. Akashi, S., Nagai, Y., Ogata, H., Oikawa, M., Fukase, K., Kusumoto, S., et al. (2001). Human MD-2 confers on mouse Toll-like receptor 4 species-specific lipopolysaccharide recognition. Int. Immunol. 13, 1595-1599.
3. Akashi, S., Shimazu, R., Ogata, H., Nagai, Y., Takeda, K., Kimoto, M., et al. (2000). Cutting edge: cell surface expression and lipopolysaccharide signaling via the toll-like receptor 4-MD-2 complex on mouse peritoneal macrophages. J. Immunol. 164, 3471-3475.
4. Aliprantis, A. O., Yang, R. B., Mark, M. R., Suggett, S., Devaux, B., Radolf, J. D., et al. (1999). Cell activation and apoptosis by bacterial lipoproteins through toll-like receptor-2. Science 285, 736-739.
5. Anisimov, A. P., Lindler, L. E., and Pier, G. B. (2004). Intraspecific diversity of Yersinia pestis. Clin. Microbiol. Rev. 17, 434-464.
6. Brubaker, R. R. (1991). Factors promoting acute and chronic diseases caused by yersiniae. Clin. Microbiol. Rev. 4, 309-324.
7. Chow, J. C., Young, D. W., Golenbock, D. T., Christ, W. J., and Gusovsky, F. (1999). Toll-like receptor-4 mediates lipopolysaccharide-induced signal transduction. J. Biol. Chem. 274, 10689-10692.
8. Clementz, T., Bednarski, J. J., and Raetz, C. R. (1996). Function of the htrB high temperature requirement gene of Escherichia coli in the acylation of lipid A: HtrB catalyzed incorporation of laurate. J. Biol. Chem. 271, 12095-12102.
9. Clementz, T., Zhou, Z., and Raetz, C. R. (1997). Function of the Escherichia coli msbB gene, a multicopy suppressor of htrB knockouts, in the acylation of lipid A. Acylation by MsbB follows laurate incorporation by HtrB. J. Biol. Chem. 272, 10353-10360.
10. Coats, S. R., Jones, J. W., Do, C. T., Braham, P. H., Bainbridge, B. W., To, T. T., et al. (2009). Human Toll-like receptor 4 responses to P. gingivalis are regulated by lipid A 1- and 4'-phosphatase activities. Cell. Microbiol. 11, 1587-1599.
11. Cornelis, G. R. (2002). The Yersinia Ysc-Yop 'type III' weaponry. Nat. Rev. Mol. Cell Biol. 3, 742-752.
12. Du, Y., Rosqvist, R., and Forsberg, A. (2002). Role of fraction 1 antigen of Yersinia pestis in inhibition of phagocytosis. Infect. Immun. 70, 1453-1460.
13. Echchannaoui, H., Frei, K., Schnell, C., Leib, S. L., Zimmerli, W., and Landmann, R. (2002). Toll-like receptor 2-deficient mice are highly susceptible to Streptococcus pneumoniae meningitis because of reduced bacterial clearing and enhanced inflammation. J. Infect. Dis. 186, 798-806.
14. Edelmann, K. H., Richardson-Burns, S., Alexopoulou, L., Tyler, K. L., Flavell, R. A., and Oldstone, M. B. (2004). Does Toll-like receptor 3 play a biological role in virus infections? Virology 322, 231-238.
15. Fransen, F., Heckenberg, S. G., Hamstra, H. J., Feller, M., Boog, C. J., van Putten, J. P., et al. (2009). Naturally occurring lipid A mutants in Neisseria meningitidis from patients with invasive meningococcal disease are associated with reduced coagulopathy. PLoS Pathog. 5:e1000396. doi:10.1371/journal.ppat.1000396
16. Galanos, C., Luderitz, O., Rietschel, E. T., Westphal, O., Brade, H., Brade, L., et al. (1985). Synthetic and natural Escherichia coli free lipid A express identical endotoxic activities. Eur. J. Biochem. 148, 1-5.
17. Gallagher, L. A., Ramage, E., Jacobs, M. A., Kaul, R., Brittnacher, M., and Manoil, C. (2007). A comprehensive transposon mutant library of Francisella novicida, a bioweapon surrogate. Proc. Natl. Acad. Sci. U.S.A. 104, 1009-1014.
18. Golenbock, D. T., Hampton, R. Y., Qureshi, N., Takayama, K., and Raetz, C. R. (1991). Lipid A-like molecules that antagonize the effects of endotoxins on human monocytes. J. Biol. Chem. 266, 19490-19498.
19. 4/MD-2 mice reveal LPS recognition differentially impacts susceptibility to Yersinia pestis and Salmonella enterica. PLoS Pathog. 8:e1002963. doi:10.1371/journal.ppat.1002963
20. Hajjar, A. M., Harvey, M. D., Shaffer, S. A., Goodlett, D. R., Sjostedt, A., Edebro, H., et al. (2006). Lack of in vitro and in vivo recognition of Francisella tularensis subspecies lipopolysaccharide by Toll-like receptors. Infect. Immun. 74, 6730-6738.
21. Hawn, T. R., Verbon, A., Lettinga, K. D., Zhao, L. P., Li, S. S., Laws, R. J., et al. (2003). A common dominant TLR5 stop codon polymorphism abolishes flagellin signaling and is associated with susceptibility to legionnaires' disease. J. Exp. Med. 198, 1563-1572.
22. Hayashi, F., Smith, K. D., Ozinsky, A., Hawn, T. R., Yi, E. C., Goodlett, D. R., et al. (2001). The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5. Nature 410, 1099-1103.
23. Haziot, A., Lin, X. Y., Zhang, F., and Goyert, S. M. (1998). The induction of acute phase proteins by lipopolysaccharide uses a novel pathway that is CD14-independent. J. Immunol. 160, 2570-2572.
24. Hemmi, H., Takeuchi, O., Kawai, T., Kaisho, T., Sato, S., Sanjo, H., et al. (2000). A Toll-like receptor recognizes bacterial DNA. Nature 408, 740-745.
25. Hinnebusch, B. J., Rudolph, A. E., Cherepanov, P., Dixon, J. E., Schwan, T. G., and Forsberg, A. (2002). Role of Yersinia murine toxin in survival of Yersinia pestis in the midgut of the flea vector. Science 296, 733-735.
26. Hochrein, H., Schlatter, B., O'Keeffe, M., Wagner, C., Schmitz, F., Schiemann, M., et al. (2004). Herpes simplex virus type-1 induces IFN-alpha production via Toll-like receptor 9-dependent and -independent pathways. Proc. Natl. Acad. Sci. U.S.A. 101, 11416-11421.
27. Homma, J. Y., Matsuura, M., Kanegasaki, S., Kawakubo, Y., Kojima, Y., Shibukawa, N., et al. (1985). Structural requirements of lipid A responsible for the functions: a study with chemically synthesized lipid A and its analogues. J. Biochem. 98, 395-406.
28. 4 as the Lps gene product. J. Immunol. 162, 3749-3752.
29. Huang, X. Z., and Lindler, L. E. (2004). The pH 6 antigen is an antiphagocytic factor produced by Yersinia pestis independent of Yersinia outer proteins and capsule antigen. Infect. Immun. 72, 7212-7219.
30. Jin, M. S., and Lee, J. O. (2008). Structures of the toll-like receptor family and its ligand complexes. Immunity 29, 182-191.
31. Kawahara, K., Tsukano, H., Watanabe, H., Lindner, B., and Matsuura, M. (2002). Modification of the structure and activity of lipid A in Yersinia pestis lipopolysaccharide by growth temperature. Infect. Immun. 70, 4092-4098.
32. Kotani, S., Takada, H., Tsujimoto, M., Ogawa, T., Takahashi, I., Ikeda, T., et al. (1985). Synthetic lipid A with endotoxic and related biological activities comparable to those of a natural lipid A from an Escherichia coli re-mutant. Infect. Immun. 49, 225-237.
33. Krieg, A. M. (2002). CpG motifs in bacterial DNA and their immune effects. Annu. Rev. Immunol. 20, 709-760.
34. Krug, A., French, A. R., Barchet, W., Fischer, J. A., Dzionek, A., Pingel, J. T., et al. (2004a). TLR9-dependent recognition of MCMV by IPC and DC generates coordinated cytokine responses that activate antiviral NK cell function. Immunity 21, 107-119.
35. Krug, A., Luker, G. D., Barchet, W., Leib, D. A., Akira, S., and Colonna, M. (2004b). Herpes simplex virus type 1 activates murine natural interferon-producing cells through toll-like receptor 9. Blood 103, 1433-1437.
36. Kumar, H., Kawai, T., and Akira, S. (2009). Toll-like receptors and innate immunity. Biochem. Biophys. Res. Commun. 388, 621-625.
37. Kusumoto, S., Fukase, K., Fukase, Y., Kataoka, M., Yoshizaki, H., Sato, K., et al. (2003). Structural basis for endotoxic and antagonistic activities: investigation with novel synthetic lipid A analogs. J. Endotoxin Res. 9, 361-366.
38. 4 agonist protects mice from pneumonic tularemia. J. Immunol. 180, 7574-7581.
39. Lund, J., Sato, A., Akira, S., Medzhitov, R., and Iwasaki, A. (2003). Toll-like receptor 9-mediated recognition of Herpes simplex virus-2 by plasmacytoid dendritic cells. J. Exp. Med. 198, 513-520.
40. Mandell, L., Moran, A. P., Cocchiarella, A., Houghton, J., Taylor, N., Fox, J. G., et al. (2004). Intact Gram-negative Helicobacter pylori, Helicobacter felis, and Helicobacter hepaticus bacteria activate innate immunity via toll-like receptor 2 but not toll-like receptor 4. Infect. Immun. 72, 6446-6454.
41. 4 by mutant Salmonella enterica serovar Typhimurium having penta-acylated lipid A. Innate Immun. 18, 764-773.
42. Matsuura, M., Kiso, M., and Hasegawa, A. (1999). Activity of monosaccharide lipid A analogues in human monocytic cells as agonists or antagonists of bacterial lipopolysaccharide. Infect. Immun. 67, 6286-6292.
43. Matsuura, M., Takahashi, H., Watanabe, H., Saito, S., and Kawahara, K. (2010). Immunomodulatory effects of Yersinia pestis lipopolysaccharides on human macrophages. Clin. Vaccine Immunol. 17, 49-55.
44. Miyake, K. (2004). Innate recognition of lipopolysaccharide by Toll-like receptor 4-MD-2. Trends Microbiol. 12, 186-192.
45. Miyake, K., Ogata, H., Nagai, Y., Akashi, S., and Kimoto, M. (2000). Innate recognition of lipopolysaccharide by Toll-like receptor 4/MD-2 and RP105/MD-1. J. Endotoxin Res. 6, 389-391.
46. Montminy, S. W., Khan, N., McGrath, S., Walkowicz, M. J., Sharp, F., Conlon, J. E., et al. (2006). Virulence factors of Yersinia pestis are overcome by a strong lipopolysaccharide response. Nat. Immunol. 7, 1066-1073.
47. Moran, A. P. (2008). Relevance of fucosylation and Lewis antigen expression in the bacterial gastroduodenal pathogen Helicobacter pylori. Carbohydr. Res. 343, 1952-1965.
48. Moran, A. P., Prendergast, M. M., and Appelmelk, B. J. (1996). Molecular mimicry of host structures by bacterial lipopolysaccharides and its contribution to disease. FEMS Immunol. Med. Microbiol. 16, 105-115.
49. Murray, G. L., Attridge, S. R., and Morona, R. (2006). Altering the length of the lipopolysaccharide O antigen has an impact on the interaction of Salmonella enterica serovar Typhimurium with macrophages and complement. J. Bacteriol. 188, 2735-2739.
50. 4 distribution. Nat. Immunol. 3, 667-672.
51. O'Brien, A. D., Metcalf, E. S., and Rosenstreich, D. L. (1982). Defect in macrophage effector function confers Salmonella typhimurium susceptibility on C3H/HeJ mice. Cell. Immunol. 67, 325-333.
52. 4/MD-2. Proc. Natl. Acad. Sci. U.S.A. 109, 7421-7426.
53. 4-MD-2 complex. Nature 458, 1191-1195.
54. Perry, R. D., and Fetherston, J. D. (1997). Yersinia pestis - etiologic agent of plague. Clin. Microbiol. Rev. 10, 35-66.
55. Phillips, N. J., Schilling, B., McLendon, M. K., Apicella, M. A., and Gibson, B. W. (2004). Novel modification of lipid A of Francisella tularensis. Infect. Immun. 72, 5340-5348.
56. 4 gene. Science 282, 2085-2088.
57. 4). J. Exp. Med. 189, 615-625.
58. Raetz, C. R., Reynolds, C. M., Trent, M. S., and Bishop, R. E. (2007). Lipid A modification systems in Gram-negative bacteria. Annu. Rev. Biochem. 76, 295-329.
59. Raetz, C. R., and Whitfield, C. (2002). Lipopolysaccharide endotoxins. Annu. Rev. Biochem. 71, 635-700.
60. Rangarajan, M., Aduse-Opoku, J., Paramonov, N., Hashim, A., Bostanci, N., Fraser, O. P., et al. (2008). Identification of a second lipopolysaccharide in Porphyromonas gingivalis W50. J. Bacteriol. 190, 2920-2932.
61. Rautemaa, R., and Meri, S. (1999). Complement-resistance mechanisms of bacteria. Microbes Infect. 1, 785-794.
62. Rebeil, R., Ernst, R. K., Gowen, B. B., Miller, S. I., and Hinnebusch, B. J. (2004). Variation in lipid A structure in the pathogenic yersiniae. Mol. Microbiol. 52, 1363-1373.
63. Rebeil, R., Ernst, R. K., Jarrett, C. O., Adams, K. N., Miller, S. I., and Hinnebusch, B. J. (2006). Characterization of late acyltransferase genes of Yersinia pestis and their role in temperature-dependent lipid A variation. J. Bacteriol. 188, 1381-1388.
64. 4 oligomerization. Int. Immunol. 16, 961-969.
65. Schromm, A. B., Brandenburg, K., Loppnow, H., Moran, A. P., Koch, M. H., Rietschel, E. T., et al. (2000). Biological activities of lipopolysaccharides are determined by the shape of their lipid A portion. Eur. J. Biochem. 267, 2008-2013.
66. Schromm, A. B., Lien, E., Henneke, P., Chow, J. C., Yoshimura, A., Heine, H., et al. (2001). Molecular genetic analysis of an endotoxin nonresponder mutant cell line: a point mutation in a conserved region of MD-2 abolishes endotoxin-induced signaling. J. Exp. Med. 194, 79-88.
67. Schumann, R. R., Leong, S. R., Flaggs, G. W., Gray, P. W., Wright, S. D., Mathison, J. C., et al. (1990). Structure and function of lipopolysaccharide binding protein. Science 249, 1429-1431.
68. Shimazu, R., Akashi, S., Ogata, H., Nagai, Y., Fukudome, K., Miyake, K., et al. (1999). MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4. J. Exp. Med. 189, 1777-1782.
69. Sjostedt, A. (2006). Intracellular survival mechanisms of Francisella tularensis, a stealth pathogen. Microbes Infect. 8, 561-567.
70. Skoglund, A., Backhed, H. K., Nilsson, C., Bjorkholm, B., Normark, S., and Engstrand, L. (2009). A changing gastric environment leads to adaptation of lipopolysaccharide variants in Helicobacter pylori populations during colonization. PLoS ONE 4:e5885. doi:10.1371/journal.pone.0005885
71. Somerville, J. E. Jr., Cassiano, L., Bainbridge, B., Cunningham, M. D., and Darveau, R. P. (1996). A novel Escherichia coli lipid A mutant that produces an antiinflammatory lipopolysaccharide. J. Clin. Invest. 97, 359-365.
72. Stead, C. M., Beasley, A., Cotter, R. J., and Trent, M. S. (2008). Deciphering the unusual acylation pattern of Helicobacter pylori lipid A. J. Bacteriol. 190, 7012-7021.
73. Straley, S. C., and Perry, R. D. (1995). Environmental modulation of gene expression and pathogenesis in Yersinia. Trends Microbiol. 3, 310-317.
74. Tabeta, K., Georgel, P., Janssen, E., Du, X., Hoebe, K., Crozat, K., et al. (2004). Toll-like receptors 9 and 3 as essential components of innate immune defense against mouse cytomegalovirus infection. Proc. Natl. Acad. Sci. U.S.A. 101, 3516-3521.
75. Takeuchi, O., Hoshino, K., and Akira, S. (2000). Cutting edge: TLR2-deficient and MyD88-deficient mice are highly susceptible to Staphylococcus aureus infection. J. Immunol. 165, 5392-5396.
76. Takeuchi, O., Kawai, T., Muhlradt, P. F., Morr, M., Radolf, J. D., Zychlinsky, A., et al. (2001). Discrimination of bacterial lipoproteins by Toll-like receptor 6. Int. Immunol. 13, 933-940.
77. Takeuchi, O., Sato, S., Horiuchi, T., Hoshino, K., Takeda, K., Dong, Z., et al. (2002). Cutting edge: role of Toll-like receptor 1 in mediating immune response to microbial lipoproteins. J. Immunol. 169, 10-14.
78. Tobias, P. S., Soldau, K., Gegner, J. A., Mintz, D., and Ulevitch, R. J. (1995). Lipopolysaccharide binding protein-mediated complexation of lipopolysaccharide with soluble CD14. J. Biol. Chem. 270, 10482-10488.
79. Viboud, G. I., and Bliska, J. B. (2005). Yersinia outer proteins: role in modulation of host cell signaling responses and pathogenesis. Annu. Rev. Microbiol. 59, 69-89.
80. Vinogradov, E., Perry, M. B., and Conlan, J. W. (2002). Structural analysis of Francisella tularensis lipopolysaccharide. Eur. J. Biochem. 269, 6112-6118.
81. Vogel, S. N., Johnson, D., Perera, P. Y., Medvedev, A., Lariviere, L., Qureshi, S. T., et al. (1999). Cutting edge: functional characterization of the effect of the C3H/HeJ defect in mice that lack an Lpsn gene: in vivo evidence for a dominant negative mutation. J. Immunol. 162, 5666-5670.
82. Wright, S. D., Ramos, R. A., Tobias, P. S., Ulevitch, R. J., and Mathison, J. C. (1990). CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 249, 1431-1433.